Skip to main content

Table 3 Association between MDR-GNB carriage and multiple exposure variables in quasi-experimental study population

From: Efficacy of a coordinated strategy for containment of multidrug-resistant Gram-negative bacteria carriage in a Neonatal Intensive Care Unit in the context of an active surveillance program

Exposure variable

OR (95% CI)

p Value

Risk of MDR-GNB carriage (adj-OR – 95% CI)

Adj-p*

Sex, ref. F

1.26 (0.52–3.10)

0.60

  

Admission in post-intervention period, ref. No

0.19 (0.06–0.51)

0.001

0.21 (0.076–0.629)

0.0047

Inborn, ref. No

6.1 (1.5–41.3)

0.02

  

Caesarean delivery, ref. No

1.9 (0.72–5.4)

0.19

  

Surgical intervention, ref. No

5.6 (0.49–64.5)

0.18

  

Gestational age, per week increase

0.87 (0.77–0.98)

0.023

  

Birth weight, per 100 gr increase

0.98 (0.97–0.99)

0.027

  

Breast milk feeding, ref. No

14.4 (2.5–313.5)

0.001

11.9 (1.49–95.9)

0.019

Nasogastric tube, ref. No

2.82 (1.15–7.1)

0.02

  

Endotracheal tube, ref. No

1.7 (0.56–4.9)

0.31

  

Ampicillin, ref. No

0.45 (0.12–1.4)

0.18

  

Ampicillin-sulbactam, ref. No

3.7 (0.98–14.4)

0.07

  

Cephalosporins, ref. No

3.1 (1.1–8.8)

0.02

  

Carbapenems, ref. No

1.02 (0.3–3.13)

1

  

Glycopeptides, ref. No

1.12 (0.35–3.5)

1

  

Fluconazole, ref. No

2.7 (0.94–7.6)

0.051

  

Duration of hospital stay before colonization, per day increase

0.96 (0.92–0.99)

0.04

  
  1. *Hosmer–Lemeshow Goodness-of-Fit Test p value = 0.94